Concerned Vaxart Stockholders Urge Fellow Stockholders to Vote “AGAINST” Reverse Stock Split and Demand Board Accountability

Core Viewpoint - Concerned Vaxart Stockholders, owning over 2.5 million shares, are urging fellow stockholders to vote "AGAINST" the proposed reverse stock split at the upcoming special meeting on September 5, 2025 [1] Group 1: Stockholder Opposition - The Board is seeking stockholder approval for a reverse stock split despite previous clear opposition from stockholders, who rejected a similar proposal at the June 13, 2025 annual meeting [2] - At the 2025 Annual Meeting, 59.1% of stockholders voted "AGAINST" the reverse stock split proposal, indicating a significant lack of confidence in the Board [3] Group 2: Board Accountability - The Board continues to act unilaterally, disregarding stockholder sentiment, and is perceived to be pursuing a value-destructive course of action [3] - The Concerned Vaxart Stockholders are calling for stockholders to unite and demand accountability from the Board regarding the reverse stock split proposal [4]